We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Automated Cell Migration System to Boost Drug Development Efforts

By LabMedica International staff writers
Posted on 01 Jun 2010
An add-on module for an integrated microscope/incubator system has recently been introduced into the market that makes it practical to study all aspects of cell migration and especially how it is affected by candidate drug compounds.

Cell migration is a multistep process that is a fundamental component of many important biological and pathological processes such as embryonic development, tissue reorganization, angiogenesis, immune cell trafficking, chronic inflammation, and tumor metastasis. More...
Cell migration is initiated by a stimulus that activates a set of signaling pathways leading to cellular polarization and a rapid reorganization of actin filaments and microtubules.

Cells advance by protruding their membrane at their leading cell border, which is followed by dynamic substrate adhesion via integrin adherence to the substrate. Membrane retraction at the lagging cell edge finishes the cycle, which is then repeated in rapid succession. The migration process is terminated when the stimulus to migrate is extinguished. In general, cell migration assays are well suited for both drug discovery and pathway analysis because they are rapid, reproducible, and can be adapted for use with many different cell types

Essen BioScience Inc. (Ann Arbor, MI, USA) recently released its CellPlayer Cell Migration 96-well assay kit as an add-on to its IncuCyte Live-Cell Imaging System. IncuCyte is a compact automated microscope that resides inside a standard tissue culture incubator.

The CellPlayer Cell Migration 96-well assay offers a precise and reproducible label-free method for monitoring the key biological processes involved in cell migration. This kinetic assay features automated data collection over a period of hours or days and generates data sets that are optimal for studying pharmacological agents and gene silencing technologies for this important function. Software built-in to IncuCyte automates the data collection process and provides the subsequent analysis for the cell migration assay.

Researchers not wishing to purchase a cell migration monitoring system can have samples evaluated by Essen's in-house service laboratory.

Related Links:
Essen BioScience Inc.




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.